My beloved dog suffers from Osteoarthritis (OA), elbow dysplasia, and hip dysplasia. These conditions are not just painful but also debilitating, affecting the quality of life of our furry friends. Unfortunately, one promising treatment - Synovetin OA®, an injectable radiotherapeutic drug for treating canine joint diseases - is not currently available in the UK.

Synovetin OA® has been shown to provide up to a year's relief from pain and inflammation associated with elbow osteoarthritis in dogs, according to studies conducted by its manufacturer, Exubrion Therapeutics. This single-dose injection can significantly improve mobility and overall quality of life for dogs suffering from these conditions.

In the UK alone, it is estimated that 1 in 5 dogs over the age of one suffer from arthritis (source: Canine Arthritis Management). That's potentially hundreds of thousands of pets who could benefit from this treatment.

We believe that our pets deserve access to all possible treatments that can alleviate their pain and improve their wellbeing. We urge the relevant health authorities and veterinary bodies in the UK to work towards making Synovetin OA® available for use within our country.

Please sign this petition if you believe every dog should have access to innovative treatments like Synovetin OA®. Let's give our best friends a chance at a better life!